The Procter & Gamble Company (NYSE:PG) Shares Bought by Smith Anglin Financial LLC

Smith Anglin Financial LLC grew its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 37.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,099 shares of the company’s stock after purchasing an additional 1,934 shares during the quarter. Smith Anglin Financial LLC’s holdings in Procter & Gamble were worth $1,230,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of PG. Alera Investment Advisors LLC lifted its holdings in shares of Procter & Gamble by 1.2% during the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after acquiring an additional 60 shares during the period. Hudson Value Partners LLC lifted its holdings in Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after purchasing an additional 60 shares during the last quarter. Fiduciary Alliance LLC boosted its position in Procter & Gamble by 2.8% in the second quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after buying an additional 61 shares in the last quarter. LCM Capital Management Inc grew its stake in Procter & Gamble by 1.1% during the first quarter. LCM Capital Management Inc now owns 5,701 shares of the company’s stock worth $925,000 after buying an additional 63 shares during the last quarter. Finally, Home Federal Bank of Tennessee increased its holdings in shares of Procter & Gamble by 0.3% during the second quarter. Home Federal Bank of Tennessee now owns 23,318 shares of the company’s stock worth $3,846,000 after buying an additional 63 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on PG. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a report on Thursday, August 29th. BNP Paribas started coverage on Procter & Gamble in a report on Monday, June 24th. They set an “outperform” rating and a $187.00 target price on the stock. Citigroup lifted their price target on Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Finally, Jefferies Financial Group downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and dropped their target price for the stock from $182.00 to $175.00 in a research note on Wednesday, July 24th. Nine equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $175.89.

Check Out Our Latest Stock Report on PG

Procter & Gamble Trading Down 0.6 %

Shares of Procter & Gamble stock traded down $1.09 during trading on Monday, hitting $167.79. 1,965,453 shares of the company were exchanged, compared to its average volume of 6,645,870. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The firm has a market capitalization of $396.01 billion, a P/E ratio of 27.46, a price-to-earnings-growth ratio of 3.73 and a beta of 0.41. The firm’s fifty day moving average price is $171.15 and its 200 day moving average price is $166.55. The Procter & Gamble Company has a 1-year low of $141.60 and a 1-year high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. The business had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm’s revenue was down .1% compared to the same quarter last year. During the same quarter last year, the business posted $1.37 EPS. As a group, sell-side analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.40%. The ex-dividend date of this dividend was Friday, July 19th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

Insider Buying and Selling at Procter & Gamble

In related news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at $6,325,360. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 383,194 shares of company stock valued at $65,140,718 in the last quarter. 0.17% of the stock is currently owned by insiders.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.